guidelines:
  1: international_prognostic_index_chronic_lymphocytic_leukemia.v0
test_cases:
- id: Very high Risk 
  input:
    1:
      gt0003|Age: 66,a
      gt0005|Serum β2 microglobulin: 4,mg/l
      gt0007|Clinical stage: 1|local::at0010|Binet B-C or Rai I-IV |
      gt0008|IGHV mutational status: 2|local::at0014|Unmutated|
      gt0009|TP53 status: 4|local::at0016|Deletion 17p (FISH) and/or TP53 mutation (sequencing)|
  expected_output:
    1:
      gt0013|CLL-IPI Score: 10.0
      gt0012|Serum β2 microglobulin, mg/L (or µg/mL): 2|local::at0012|>3.5|
      gt0015|5-year survival: local::at0027|23.3%|
      gt0011|Age: 1|local::at0008|>65 years|
      gt0014|Risk: local::at0022|Very high risk|

- id: High Risk
  input:
    1:
      gt0003|Age: 66,a
      gt0005|Serum β2 microglobulin: 4,mg/l
      gt0007|Clinical stage: 1|local::at0010|Binet B-C or Rai I-IV |
      gt0008|IGHV mutational status: 2|local::at0014|Unmutated|
      gt0009|TP53 status: 0|local::at0015|No abnormalities|
  expected_output:
    1:
      gt0013|CLL-IPI Score: 6.0
      gt0012|Serum β2 microglobulin, mg/L (or µg/mL): 2|local::at0012|>3.5|
      gt0015|5-year survival: local::at0026|63.3%|
      gt0011|Age: 1|local::at0008|>65 years|
      gt0014|Risk: local::at0021|High risk|

- id: Intermediate Risk
  input:
    1:
      gt0003|Age: 66,a
      gt0005|Serum β2 microglobulin: 4,mg/l
      gt0007|Clinical stage: 0|local::at0009|Binet A or Rai 0|
      gt0008|IGHV mutational status: 0|local::at0013|Mutated|
      gt0009|TP53 status: 0|local::at0015|No abnormalities|
  expected_output:
    1:
      gt0013|CLL-IPI Score: 3.0
      gt0012|Serum β2 microglobulin, mg/L (or µg/mL): 2|local::at0012|>3.5|
      gt0015|5-year survival: local::at0025|79.3%|
      gt0011|Age: 1|local::at0008|>65 years|
      gt0014|Risk: local::at0020|Intermediate risk|

- id: Low Risk
  input:
    1:
      gt0003|Age: 64,a
      gt0005|Serum β2 microglobulin: 2,mg/l
      gt0007|Clinical stage: 0|local::at0009|Binet A or Rai 0|
      gt0008|IGHV mutational status: 0|local::at0013|Mutated|
      gt0009|TP53 status: 0|local::at0015|No abnormalities|
  expected_output:
    1:
      gt0013|CLL-IPI Score: 0.0
      gt0012|Serum β2 microglobulin, mg/L (or µg/mL): 0|local::at0011|≤3.5|
      gt0015|5-year survival: local::at0024|93.2%|
      gt0011|Age: 0|local::at0007|≤65 years|
      gt0014|Risk: local::at0019|Low risk|